Related Experiment Video

Updated: Jul 6, 2025

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
10:29

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

1.1K

Tecovirimat for Mpox-Promise and Limitations

Jason Zucker1, William A Fischer2, Timothy Wilkin3

  • 1Division of Infectious Diseases, Columbia University Vagelos College of Physicians and Surgeons, New York, New York.

JAMA Internal Medicine
|January 8, 2024
PubMed
Summary

No abstract available in PubMed .

More Related Videos

Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs
10:44

Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs

Published on: May 15, 2019

13.2K
Prediction of HIV-1 Coreceptor Usage Tropism by Sequence Analysis using a Genotypic Approach
07:06

Prediction of HIV-1 Coreceptor Usage Tropism by Sequence Analysis using a Genotypic Approach

Published on: December 1, 2011

13.3K

Related Experiment Videos

Last Updated: Jul 6, 2025

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
10:29

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

1.1K
Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs
10:44

Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs

Published on: May 15, 2019

13.2K
Prediction of HIV-1 Coreceptor Usage Tropism by Sequence Analysis using a Genotypic Approach
07:06

Prediction of HIV-1 Coreceptor Usage Tropism by Sequence Analysis using a Genotypic Approach

Published on: December 1, 2011

13.3K

Related Concept Videos

Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

180
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
180

Articles linked to this work by shared authors, journal, and citation graph.

Bacterial Infection in Ebola Virus Disease, Marburg Virus Disease, Crimean-Congo Hemorrhagic Fever, and Lassa Fever.

Open forum infectious diseases·2026

Tecovirimat treatment of clade II mpox: a virological analysis of a randomised, double-blind, phase 3 trial.

The Lancet. Microbe·2026

Food insecurity in New York City college students during the COVID-19 pandemic: a longitudinal analysis of predictors, correlates, and trajectories.

Journal of American college health : J of ACH·2026

Alcohol consumption and oral human papillomavirus infection among men living with HIV: a cross-sectional study from the ULACNet 201 trial.

Scientific reports·2026

Patient Information, Motivations, and Behavioral Skills during Early Implementation of Doxy-PEP in New York City.

Sexually transmitted diseases·2026

A Randomized Controlled Trial of a Digital Patient Decision Tool to Increase Sexually Transmitted Infection Testing in the Emergency Department.

Annals of emergency medicine·2026

Health Communication and Stepped Reminders Interventions for Lung Cancer Screening: A Randomized Clinical Trial.

JAMA internal medicine·2026

Medicare Advantage and Type 2 Diabetes Outcomes.

JAMA internal medicine·2026

Autonomous Oxygen Titration for Maintaining Normoxemia in Acutely Ill Adults: The SAVE-O2 AI Randomized Clinical Trial.

JAMA internal medicine·2026

Continuous Glucose Monitoring in Type 2 Diabetes and Beyond: A Review.

JAMA internal medicine·2026

An Indigenous Food Is Medicine Intervention: The MUTTON-HF Randomized Clinical Trial.

JAMA internal medicine·2026

High-Efficiency Particulate Air Filters to Prevent Winter Respiratory Infections in Care Homes: The AFRI-c Cluster Randomized Clinical Trial.

JAMA internal medicine·2026

The MEG3-miRNA regulatory axis could potentially modulate response to biological therapies in psoriatic arthritis.

Pharmacological reports : PR·2026

Validation of low-volume plasma dilution protocols for human cytomegalovirus DNA quantification using the cobas CMV assay.

Microbiology spectrum·2026

Discovery of four novel phenuiviruses from public mosquito RNA-seq data using reference-guided assembly.

Microbiology resource announcements·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us